Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

D-Wave Quantum Inc. Director's Dealing 2024

Jan 16, 2024

30690_dirs_2024-01-16_fd2e2151-6312-484c-b5f6-50b8d568e180.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: D-Wave Quantum Inc. (QBTS)
CIK: 0001907982
Period of Report: 2024-01-10

Reporting Person: Nguyen Diane (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-01-10 Common Stock, par value $0.0001 per share ("Common Stock") A 36351 Acquired 299156 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-01-10 Stock Option (right to buy) $0.846 A 58255 Acquired 2034-01-10 Common Stock (58255) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $0.91 2030-05-05 Common Stock (16592) 16592 Direct
Stock Option (right to buy) $0.91 2030-05-05 Common Stock (27668) 27668 Direct
Stock Option (right to buy) $0.91 2030-11-17 Common Stock (9118) 9118 Direct
Stock Option (right to buy) $0.92 2031-08-20 Common Stock (53379) 53379 Direct

Footnotes

F1: Includes: (a) 178,672 shares of unvested restricted stock units: (i) 93,312 RSUs granted on October 13, 2022 and vesting as follows: 46,656 on October 13, 2024 and October 13, 2025, and (ii) 85,360 RSUs granted on March 27, 2023 and vesting as follows: 21,340 on March 27, 2024 and the remaining 54,020 will vest quarterly at a rate of 6.25% beginning July 27, 2024, and (b) 8,162 Common Stock acquired under the Employee Stock Purchase Plan ("ESPP") of D-Wave Quantum Inc. (the "Issuer"). In accordance with the ESPP, the 8,162 Common Stock were purchased at a price equal to 85% of the closing price of the Issuer's Common Stock on November 30, 2023.

F2: This option has vested and is exercisable as of the grant date as to all 58,255 shares of Common Stock.

F3: This option has vested and is exercisable as of the date hereof as to all 16,592 shares of Common Stock.

F4: The option has vested and is exercisable as of the date hereof as to 25,364 shares of Common Stock and the remaining portion of the option vests in equal monthly installments on the 5th of each month through May 5, 2024 as to 2,304 shares of Common Stock.

F5: The option has vested and is exercisable as of the date hereof as to 7,222 shares of Common Stock and the remaining portion of the option vests in equal monthly installments on the 1st of each month through November 1, 2024 as to 1,896 shares of Common Stock.

F6: The option has vested and is exercisable as of the date hereof as to 32,251 shares of Common Stock and the remaining portion of the option vests in equal monthly installments on the 16th of each month through July 16, 2025 as to 21,128 shares of Common Stock.